Study Shows HIV Remission Is Possible for Children Started on Very Early Antiretroviral Therapy

Research co-led by an investigator at Johns Hopkins Children’s Center shows that four children born with HIV who were safely removed from antiretroviral therapy (ART) continued to have undetectable levels of the virus for about a year or more without treatment. The children were among 54 newborns who were given very early treatment within the first 48 hours of life — rather than within weeks or months, as is typical.
[email protected]

SLU Researcher Receives $1.76 Million NIH Grant to Create STAR, an HIV-Focused Experiential Research and Capacity Building Program for Students and Young Researchers

Using a crowdsourcing framework utilized over the past five years, Juliet Iwelunmor, Ph.D., professor of global health and behavioral science and health education at Saint Louis University’s College for Public Health and Social Justice, is taking what she learned from empowering youth in Nigeria to identify young people in the United States who aim to become the next generation of HIV researchers, leaders and innovators in the field.

New insights into HIV latent cells yield potential cure targets

In a presentation today at AIDS 2022, the 24th International AIDS Conference in Montreal, scientists with the National Institute of Allergy and Infectious Diseases’ (NIAID) Vaccine Research Center (VRC) and their collaborators described how their use of cutting-edge technology revealed new insights into cellular reservoirs of HIV and what those observations could mean for the next steps in HIV cure research. NIAID is part of the National Institutes of Health.

Albert Einstein College of Medicine Receives $11.3M NIH Grant to Expand the Einstein-Rockefeller-CUNY Center for AIDS Research

The National Institutes of Health (NIH) has awarded Albert Einstein College of Medicine a five-year, $11.3 million grant to renew the Einstein-Rockefeller-CUNY Center for AIDS Research (ERC-CFAR) and expand its efforts to prevent, treat and cure HIV infection, and thereby reduce the burden of HIV, locally, nationally, and internationally.

Rutgers Expert Available to Speak About COVID-19 and Heightened Risk for Those Living with HIV

Preliminary data has shown that people living with HIV may be at heightened risk for severe complications from COVID-19 because they are simultaneously experiencing two epidemics that are synergistically interacting to create increased odds of death and disability. However, HIV…

Twitter chat with HIV/AIDS experts from the Johns Hopkins School of Nursing, Nov. 26, to prepare for World AIDS Day

The Johns Hopkins School of Nursing @JHUNursing is hosting a Twitter Chat in advance of World AIDS Day featuring its practitioners, researchers, and experts in HIV care, prevention, and science. Tuesday, November 26, 4:00 pm, EST Join and ask questions…

Stephanie Shiau Joins the Rutgers School of Public Health

New Brunswick, NJ – The Rutgers School of Public Health is excited to announce that Stephanie Shiau, PhD, will be joining the department of biostatistics and epidemiology as an instructor in August.  Shiau’s research focuses on the effects of human immunodeficiency virus (HIV)…